Executive Summary
H&R GmbH & Co. KGaA manufactures and sells chemical-pharmaceutical raw materials and injection molded precision plastic parts.
Rewards
Risk Analysis
Snowflake Analysis
Adequate balance sheet with moderate growth potential.
Share Price & News
How has H&R GmbH KGaA's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 2HRA's share price has been volatile over the past 3 months.
Market Performance
7 Day Return
-2.0%
2HRA
4.2%
DE Chemicals
3.1%
DE Market
1 Year Return
-10.5%
2HRA
1.7%
DE Chemicals
14.0%
DE Market
Return vs Industry: 2HRA underperformed the German Chemicals industry which returned 1.7% over the past year.
Return vs Market: 2HRA underperformed the German Market which returned 14% over the past year.
Shareholder returns
| 2HRA | Industry | Market | |
|---|---|---|---|
| 7 Day | -2.0% | 4.2% | 3.1% |
| 30 Day | -6.7% | 2.2% | 2.3% |
| 90 Day | 44.9% | 21.0% | 18.4% |
| 1 Year | -10.5%-10.5% | 6.1%1.7% | 16.5%14.0% |
| 3 Year | -51.9%-53.6% | -17.6%-26.4% | 7.4%-1.2% |
| 5 Year | -23.1%-25.8% | -2.8%-18.7% | 23.8%7.2% |
Price Volatility Vs. Market
How volatile is H&R GmbH KGaA's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall St
How Much Did H&R GmbH KGaA's(ETR:2HRA) Shareholders Earn From Share Price Movements Over The Last Three Years?2 months ago | Simply Wall St
Brokers Are Upgrading Their Views On H&R GmbH & Co. KGaA (ETR:2HRA) With These New Forecasts3 months ago | Simply Wall St
What Type Of Shareholder Owns H&R GmbH & Co. KGaA's (ETR:2HRA)?Valuation
Is H&R GmbH KGaA undervalued compared to its fair value and its price relative to the market?
0.62x
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: 2HRA (€5.45) is trading above our estimate of fair value (€1.14)
Significantly Below Fair Value: 2HRA is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 2HRA is unprofitable, so we can't compare its PE Ratio to the DE Chemicals industry average.
PE vs Market: 2HRA is unprofitable, so we can't compare its PE Ratio to the German market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 2HRA's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 2HRA is good value based on its PB Ratio (0.6x) compared to the DE Chemicals industry average (1.4x).
Next Steps
Future Growth
How is H&R GmbH KGaA forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
101.6%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2HRA is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.2%).
Earnings vs Market: 2HRA is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 2HRA's is expected to become profitable in the next 3 years.
Revenue vs Market: 2HRA's revenue is expected to decline over the next 3 years (-1.2% per year).
High Growth Revenue: 2HRA's revenue is forecast to decline over the next 3 years (-1.2% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 2HRA's Return on Equity is forecast to be high in 3 years time
Next Steps
Past Performance
How has H&R GmbH KGaA performed over the past 5 years?
-11.8%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 2HRA is currently unprofitable.
Growing Profit Margin: 2HRA is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: 2HRA is unprofitable, and losses have increased over the past 5 years at a rate of 11.8% per year.
Accelerating Growth: Unable to compare 2HRA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 2HRA is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-15.2%).
Return on Equity
High ROE: 2HRA has a negative Return on Equity (-2.62%), as it is currently unprofitable.
Next Steps
Financial Health
How is H&R GmbH KGaA's financial position?
Financial Position Analysis
Short Term Liabilities: 2HRA's short term assets (€313.6M) exceed its short term liabilities (€244.8M).
Long Term Liabilities: 2HRA's short term assets (€313.6M) exceed its long term liabilities (€208.6M).
Debt to Equity History and Analysis
Debt Level: 2HRA's debt to equity ratio (49.1%) is considered high.
Reducing Debt: 2HRA's debt to equity ratio has reduced from 76% to 49.1% over the past 5 years.
Debt Coverage: 2HRA's debt is well covered by operating cash flow (31.5%).
Interest Coverage: Insufficient data to determine if 2HRA's interest payments on its debt are well covered by EBIT.
Balance Sheet
Next Steps
Dividend
What is H&R GmbH KGaA current dividend yield, its reliability and sustainability?
1.43%
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 2HRA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 2HRA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 2HRA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 2HRA's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: 2HRA is not paying a notable dividend for the German market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 2HRA's dividend in 3 years as they are not forecast to pay a notable one for the German market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
8.3yrs
Average board tenure
CEO
Niels Hansen (55 yo)
8.58yrs
Tenure
Mr. Niels H. Hansen serves as the Managing Director of Hansen & Rosenthal KG. Mr. Hansen has been Managing Director and Chairman of The Executive Board at H&R GmbH & Co. KGaA since January 01, 2012. Mr. Ha ...
CEO Compensation Analysis
Compensation vs Market: Niels's total compensation ($USD0.00) is below average for companies of similar size in the German market ($USD750.01K).
Compensation vs Earnings: Niels's compensation has increased whilst the company is unprofitable.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Honorary Chairman of Supervisory Board | 8.17yrs | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Employee Representative Member of the Supervisory Board | 18yrs | €30.00k | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Independent Member of Supervisory Board | 9.83yrs | €45.00k | no data | |
| Member of Advisory Board | no data | no data | 5.45% € 11.1m | |
| Vice Chairman of Supervisory Board | 8.58yrs | €65.00k | no data | |
| Employee Representative Member of the Supervisory Board | 3.33yrs | €30.00k | no data | |
| Chairman of Supervisory Board | 8.25yrs | €115.00k | no data | |
| Employee Representative Member of the Supervisory Board | 8.25yrs | €30.00k | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Supervisory Board | 4.08yrs | €50.00k | no data |
8.3yrs
Average Tenure
60.5yo
Average Age
Experienced Board: 2HRA's board of directors are considered experienced (8.3 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
H&R GmbH & Co. KGaA's company bio, employee growth, exchange listings and data sources
Key Information
- Name: H&R GmbH & Co. KGaA
- Ticker: 2HRA
- Exchange: XTRA
- Founded: 1919
- Industry: Specialty Chemicals
- Sector: Materials
- Market Cap: €202.859m
- Shares outstanding: 37.22m
- Website: https://www.hur.com
Number of Employees
Location
- H&R GmbH & Co. KGaA
- Neuenkirchener Strasse 8
- Salzbergen
- Lower Saxony
- 48499
- Germany
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 2HRA | DB (Deutsche Boerse AG) | Yes | Ordinary Bearer Shares | DE | EUR | Jan 1992 |
| 2HRA | XTRA (XETRA Trading Platform) | Yes | Ordinary Bearer Shares | DE | EUR | Jan 1992 |
| 0RRC | LSE (London Stock Exchange) | Yes | Ordinary Bearer Shares | GB | EUR | Jan 1992 |
| 2HRAD | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | Ordinary Bearer Shares | GB | EUR | Jan 1992 |
Biography
H&R GmbH & Co. KGaA manufactures and sells chemical-pharmaceutical raw materials and injection molded precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales, and P ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/08/14 10:27 |
| End of Day Share Price | 2020/08/13 00:00 |
| Earnings | 2020/03/31 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.